Effects of Dietary Microencapsulated Fermented Pangasius Byproduct Extract on Growth Performance, Hematological Indices, and Abdominal Fat Deposition in Broiler Chickens
Advances in Agriculture · 2026-01 · 2026 (1)
DOI: 10.1155/aia/2401922 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Agriculture, online erschienen am 29.07.2026. Verfasst von Abun Abun und 2 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitas Padjadjaran.
Abstract (Originalsprache)
Routine antibiotic growth‐promoter (AGP) use in poultry production has declined because of concerns about antimicrobial resistance and residues in animal products. This study evaluated microencapsulated fermented Pangasius byproduct extract (MFPBE) as an experimental post‐bioprocessed feed‐additive candidate for broiler chickens, with responses interpreted against both an unsupplemented basal diet and an active zinc bacitracin positive control. A total of 300 mixed‐sex Cobb‐500 broilers were allocated to six dietary treatments for 35 days, with five replicate pens per treatment and 10 birds per pen. Treatments comprised a basal diet (T−), a basal diet supplemented with zinc bacitracin to provide 100 ppm active ingredient (T+), and basal diets in which MFPBE replaced 0.5%, 1.0%, 1.5%, or 2.0% of the basal diet. Dietary treatment affected body weight gain (BWG), feed intake (FI), protein intake (PI), abdominal fat percentage, and hematological indices ( p < 0.05), but did not affect feed conversion ratio (FCR), protein efficiency ratio (PER), slaughter weight, carcass weight, or carcass percentage. The 2.0% MFPBE group had BWG of 1485.4 g/bird compared with 1321.1 g/bird in T− and 1472.8 g/bird in T+, and FI of 2634.9 g/bird compared with 2171.5 g/bird in T−. However, FCR and PER were not improved (T2.0: 1.77 and 2.65; T−: 1.64 and 2.86), indicating an intake‐driven response rather than improved feed efficiency. The 2.0% MFPBE group also had greater abdominal fat than T− (2.04% vs. 1.52%). The 0.5% MFPBE group showed the highest erythrocyte count (2.71 × 10 6 /mm 3 ), leukocyte count (137.20 × 10 3 /mm 3 ), and hemoglobin concentration (11.25 g/dL), whereas T0.5 and T2.0 shared the highest H/L‐ratio superscript group (0.20 and 0.19, respectively). These hematological changes indicate blood‐cell profile modulation and possible leukocyte redistribution or physiological activation, not definitive immune enhancement. MFPBE cannot yet be claimed as an AGP replacement without microbiological safety, gut‐health, and pathogen‐challenge validation.
Förderung
- Universitas Padjadjaran
Zitieren
APA
Abun, A., Haetami, K., & Ramdhan, R. F. (2026). Effects of Dietary Microencapsulated Fermented Pangasius Byproduct Extract on Growth Performance, Hematological Indices, and Abdominal Fat Deposition in Broiler Chickens. Advances in Agriculture, 2026(1). https://doi.org/10.1155/aia/2401922
Vancouver
Abun A, Haetami K, Ramdhan RF. Effects of Dietary Microencapsulated Fermented Pangasius Byproduct Extract on Growth Performance, Hematological Indices, and Abdominal Fat Deposition in Broiler Chickens. Advances in Agriculture. 2026;2026(1). doi:10.1155/aia/2401922
BibTeX
@article{Abun2026,
author = {Abun, Abun and Haetami, Kiki and Ramdhan, Rahmad Fani},
title = {Effects of Dietary Microencapsulated Fermented Pangasius Byproduct Extract on Growth Performance, Hematological Indices, and Abdominal Fat Deposition in Broiler Chickens},
journal = {Advances in Agriculture},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/aia/2401922}
}
EUVIMED